![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Procaterol.svg/640px-Procaterol.svg.png&w=640&q=50)
Procaterol
Pharmaceutical drug / From Wikipedia, the free encyclopedia
Procaterol is an intermediate-acting[citation needed] β2 adrenoreceptor agonist used for the treatment of asthma. It has never been filed for FDA evaluation in the United States, where it is not marketed. The drug is readily oxidized in the presence of moisture and air, making it unsuitable for therapeutic use by inhalation.[1] Pharmaceutical company Parke-Davis/Warner-Lambert researched a stabilizer to prevent oxidation, but an effective one was never developed.[1]
Quick Facts Clinical data, Trade names ...
![]() | |
Clinical data | |
---|---|
Trade names | Meptin, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Oral (tablets, syrup), inhalation (DPI) |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.069.606 ![]() |
Chemical and physical data | |
Formula | C16H22N2O3 |
Molar mass | 290.363 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
![]() ![]() |
Close
It was patented in 1974 and came into medical use in 1980.[2]